Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.60 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.60 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.60 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.60 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.59 |
| ▸ | PKM | P14618 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | IDE | P14735 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31510305 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL31661152 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL31510307 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL31225700 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL24637661 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL23077610 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL15315671 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12937922 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL19543682 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL29468062 | 1.00 | F2 (0.60) | F2PRSS1PRSS2PRSS3TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119667172-A | Magnetic bead coated antigen applied to screening IL-6 antibody | 广州达安基因股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-20250236863-A1 | High Throughput Assays for Identifying the Biological Response of a Cell | Zafrens Inc. (US) | 2025-07-24 | — | — | US | disclosed |
| CN-119667172-A | Magnetic bead coated antigen applied to screening IL-6 antibody | 广州达安基因股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4519385-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119555930-A | Photo-activated chemiluminescence detection reagent composition, kit, detection method and device | 科美诊断技术股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119524822-A | Preparation method of novel suspended array bar code microsphere of mass flow cytometer | 四川大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-115656154-B | Anti-RNP antibody chemiluminescence detection kit based on recombinant RNP multiple antigens | 广东优尼德生物科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-115656153-B | Anti-nuclear antibody spectrum detection kit based on acridinium ester chemiluminescence | 广东优尼德生物科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| US-20240191211-A1 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION | 2024-06-13 | — | — | US | disclosed |
| US-11952434-B2 | Immunomodulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-04-09 | — | — | US | disclosed |
| US-20100261181-A1 | LABELING AND DETECTION OF NUCLEIC ACIDS | Life Technologies Corporation (US) | 2010-10-14 | — | — | US | disclosed |
| US-20100075435-A1 | BIOTINYLATED THYROXINE | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20100075435-A1 | BIOTINYLATED THYROXINE | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090170218-A1 | METHODS FOR DETECTION OF CYCLOSPORIN A | DADE BEHRING INC. (US) | 2009-07-02 | — | — | US | disclosed |
| WO-2008101024-A2 | LABELING AND DETECTION OF NUCLEIC ACIDS | INVITROGEN CORPORATION (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008029281-A2 | LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS | INVITROGEN CORPORATION (US) | 2008-03-13 | — | — | WO | disclosed |
| US-20080050731-A1 | LABELING AND DETECTION OF NUCLEIC ACIDS | INVITROGEN CORPORATION (US) | 2008-02-28 | — | — | US | disclosed |
| US-20080050731-A1 | LABELING AND DETECTION OF NUCLEIC ACIDS | INVITROGEN CORPORATION (US) | 2008-02-28 | — | — | US | disclosed |
| US-20070249014-A1 | LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS | INVITROGEN CORPORATION (US) | 2007-10-25 | — | — | US | disclosed |
| US-20070249014-A1 | LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS | INVITROGEN CORPORATION (US) | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11952434-B2 | Immunomodulators | CD74, ICOS, HAVCR2 | F2 4461/4885PRSS1 3406/4885PRSS2 4139/4885 |
| US-20100075435-A1 | BIOTINYLATED THYROXINE | TPO, TSHR, THRB | F2 217/4885PRSS1 2202/4885PRSS2 1347/4885 |
| US-20090170218-A1 | METHODS FOR DETECTION OF CYCLOSPORIN A | CHP1, PPP3R1, SERPINA6 | F2 3563/4885PRSS1 152/4885PRSS2 327/4885 |
| US-20070249014-A1 | LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS | PTMS, DNPEP, BTD | F2 4562/4885PRSS1 1565/4885PRSS2 1846/4885 |
| US-20100261181-A1 | LABELING AND DETECTION OF NUCLEIC ACIDS | RNGTT, ADAR, ALKBH1 | F2 4860/4885PRSS1 3082/4885PRSS2 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.